All UK & Rest of Europe articles – Page 14
-
NewsExeter launches second round of global funding to tackle antifungal drug resistance
A University of Exeter funding scheme designed to combat the global challenge of fungal antimicrobial resistance (fAMR) has announced a new call for applications.
-
NewsStudy shows head trauma may activate latent viruses, leading to neurodegeneration
Researchers have uncovered mechanisms that may connect the dots between trauma and the emergence of disease, pointing to latent viruses lurking in most of our brains that may be activated by the jolt, leading to inflammation and accumulating damage.
-
NewsTuberculosis strains resistant to new drugs are transmitted between patients
Researchers have identified 514 Mycobacterium tuberculosis strains that are resistant to TB drugs, including both old and new treatment regimens, in 27 countries across four continents. 28% of these strains were transmitted directly from one patient to another.
-
NewsA healthy diet is key to a healthy gut microbiome
Vegan, vegetarian and omnivorous diets affect intestinal microorganisms, but the absence of certain foods from the diet can have complex effects that can be positively or negatively correlated with general well-being.
-
NewsSystem to auto-detect new variants will inform better response to future infectious disease outbreaks
Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in humans - including those causing flu, COVID, whooping cough and tuberculosis.
-
NewsBacteria to the rescue: a sustainable solution for growing organoids
Researchers have developed a new way to grow organoids using Invasin, a protein produced by bacteria, offering a sustainable, affordable and animal-free alternative to currently used methods.
-
CareersThe Space Microbiology Group
The Space Microbiology Group studies how microorganisms behave in space conditions, using tools such as microbiology, molecular biology, system biology and geomicrobiology to learn how new biotechnologies could be applied to space.
-
NewsEvolutionary study reveals the toxic reach of disease-causing bacteria across the plant kingdom
The capacity of bacteria to spread disease across the plant kingdom may be much more widespread than previously suspected, according to a comparative evolutionary analysis, using the diversity of Pseudomonas syringae bacteria.
-
NewsThe role of understudied dysfunctional immune cells in severe COVID-19: new research
A new study focuses on understanding how ‘notoriously understudied’ immune cells behave abnormally in patients with severe COVID-19 and provides insights into mechanism behind COVID-19 disease progression.
-
NewsConnectivity loss in pond networks threatens microbial biodiversity
A recent study explored the effects of connectivity loss within pond networks, using an outdoor experimental setup of artificial ponds (mesocosms).
-
NewsPhytochromes: The ‘eyes’ that enable microalgae to find their way in the depths
By studying the light perception process of diatoms, a group of phytoplankton, scientists have discovered that these microalgae use light variation sensors which are codified in their genomes: phytochromes.
-
NewsAfter lockdown, immune system reacts more strongly to viruses and bacteria
The lockdowns during the COVID-19 pandemic had a significant impact on people’s immune response to microorganisms. During the lockdown, inflammation level in the body was low, but afterwards, the immune system reacted more intensely to viruses and bacteria.
-
NewsSyphilis had its roots in the Americas, archaeological bone reveals
New research supports a root in the Americas for syphilis and its known relatives, and their introduction to Europe starting in the late 15th century is most consistent with the data, scientists say.
-
NewsCheese starter cultures yield insights into history of domestication of bacteria
A new study shows that the bacteria used to produce Gruyère, Emmental and Sbrinz cheese show signs of ancient domestication.
-
NewsStart-up EBViously announces its launch
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).
-
NewsPediatric investigation study confirms the safety of COVID-19 vaccination during pregnancy
A new study shows that maternal COVID-19 vaccination is not associated with adverse health outcomes in infants.
-
NewsScientists find a vulnerability in antibiotic resistance mechanism
Superbugs, bacteria that are immune to multiple antibiotics, pose a great challenge to modern medicine. Researchers from the B CUBE - Center for Molecular Bioengineering at TUD Dresden University of Technology and Institut Pasteur in Paris identified a weakness in the bacterial machinery that drives antibiotic resistance adaptation. Their findings, ...
-
NewsGenome researchers unfurl protective mantle of influenza virus
The structure of the flu virus’s protective mantle and its interactions with its RNA have been described on an atomic scale by a research team for the first time.
-
NewsBreakthrough infection test designed to tackle AMR on target for 2025 UK NHS availability after positive trial results
UK medtech company Presymptom Health has announced positive results from its clinical trial of diagnostic technology in the management of infection and sepsis in patients presenting to Emergency Departments with respiratory infection.
-
NewsPatients whose allergies cause the sniffles have different fungi living in their noses, compared to healthy people
Scientists investigated the noses of people with asthma and allergic rhinitis and found that the fungi in their noses are different to healthy people, suggesting future targets for treatments.